The use of animal models in developing the discipline of cardiovascular tissue engineering: a review.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 14697864)

Published in Biomaterials on April 01, 2004

Authors

S Tawqeer Rashid1, Henryk J Salacinski, George Hamilton, Alexander M Seifalian

Author Affiliations

1: Tissue Engineering Centre, University Department of Surgery, Royal Free and University College Medical School, University College London, Royal Free Hospital, Pond Street, London, NW3 2QG, UK.

Articles citing this

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials (2007) 1.90

Development of small-diameter vascular grafts. World J Surg (2007) 1.27

Electrospun PGA/gelatin nanofibrous scaffolds and their potential application in vascular tissue engineering. Int J Nanomedicine (2011) 0.91

An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia. J Cardiovasc Transl Res (2011) 0.86

Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model. Biomaterials (2011) 0.85

Predicting in vivo responses to biomaterials via combined in vitro and in silico analysis. Tissue Eng Part C Methods (2014) 0.85

Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta Biomater (2009) 0.84

ECM-based materials in cardiovascular applications: Inherent healing potential and augmentation of native regenerative processes. Int J Mol Sci (2009) 0.84

The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev (2015) 0.79

Suitability of the rat subdermal model for tissue engineering of heart valves. Med Sci Monit Basic Res (2014) 0.77

Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo. Front Pharmacol (2016) 0.77

A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio. PLoS One (2016) 0.75

Articles by these authors

Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med (2009) 10.60

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet (2012) 4.54

Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci (2004) 2.54

Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol (2010) 2.41

Biological applications of quantum dots. Biomaterials (2007) 2.22

Renovascular hypertension in children. Lancet (2008) 2.17

The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl (2005) 2.04

Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater (2008) 2.01

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci (2009) 1.98

Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J Surg Res (2008) 1.81

Recognition and management of abdominal compartment syndrome in the United Kingdom. Intensive Care Med (2006) 1.76

The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials (2005) 1.75

Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg (2007) 1.56

Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater (2005) 1.56

Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol (2007) 1.51

Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU Int (2013) 1.46

Vascular surgery by numbers. Ann R Coll Surg Engl (2007) 1.43

Polymeric heart valves: new materials, emerging hopes. Trends Biotechnol (2009) 1.41

Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. Acc Chem Res (2005) 1.31

Area-wide management of Aedes albopictus. Part 2: gauging the efficacy of traditional integrated pest control measures against urban container mosquitoes. Pest Manag Sci (2013) 1.31

The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis (2005) 1.30

Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Biochem (2007) 1.27

Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules (2008) 1.27

Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation (2007) 1.22

Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg (2003) 1.22

Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg (2003) 1.21

A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine (2011) 1.20

The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine (2010) 1.18

Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol (2005) 1.13

Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12

Vascular risk factors in South Asians. Int J Cardiol (2008) 1.11

In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng (2009) 1.10

Impairment of hepatic microcirculation in fatty liver. Microcirculation (2003) 1.10

Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev (2012) 1.10

Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med (2009) 1.09

Modern surgical management of peripheral nerve gap. J Plast Reconstr Aesthet Surg (2010) 1.09

Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int J Nanomedicine (2011) 1.09

Virulence of select entomopathogenic fungi to the brown marmorated stink bug, Halyomorpha halys (Stål) (Heteroptera: Pentatomidae). Pest Manag Sci (2012) 1.08

Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs (2002) 1.08

Stem cells and cancer: an overview. Stem Cell Rev (2007) 1.07

Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05

Nerve conduits for peripheral nerve surgery. Plast Reconstr Surg (2014) 1.04

Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03

Tissue engineering of small intestine--current status. Biomacromolecules (2006) 1.01

Effect of graduated compression stockings on limb oxygenation and venous function during exercise in patients with venous insufficiency. Vascular (2004) 1.01

Functionalization of single-walled carbon nanotubes and their binding to cancer cells. Int J Nanomedicine (2012) 1.00

Mid-aortic syndrome: long-term outcome of 36 children. Pediatr Nephrol (2009) 0.99

Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review. J Drug Target (2010) 0.99

Results of surgical treatment for renovascular hypertension in children: 30 year single centre experience. Nephrol Dial Transplant (2009) 0.99

Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput (2007) 0.98

The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J (2002) 0.97

Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97

The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules (2006) 0.97

The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials (2005) 0.96

Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater (2011) 0.96

A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res (2002) 0.95

Nitric oxide: a guardian for vascular grafts? Chem Rev (2011) 0.95

Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis (2004) 0.95

Quantitating therapeutic disruption of tumor blood flow with intravital video microscopy. Cancer Res (2006) 0.95

A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS). Macromol Rapid Commun (2011) 0.95

Source reduction behavior as an independent measurement of the impact of a public health education campaign in an integrated vector management program for the Asian tiger mosquito. Int J Environ Res Public Health (2011) 0.95

Tissue engineering: revolution and challenge in auricular cartilage reconstruction. Plast Reconstr Surg (2012) 0.94

Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J Biomech (2012) 0.94

The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys (2006) 0.93

Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol (2005) 0.93

Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J (2002) 0.93

In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold. Biotechnol Appl Biochem (2009) 0.93

Skin regeneration scaffolds: a multimodal bottom-up approach. Trends Biotechnol (2012) 0.92

Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules (2004) 0.92

Effect of remote ischemic preconditioning on liver ischemia/reperfusion injury using a new mouse model. Liver Transpl (2011) 0.92

Addressing thrombogenicity in vascular graft construction. J Biomed Mater Res B Appl Biomater (2007) 0.91

Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg (2009) 0.91

Development and implementation of a reduced risk peach arthropod management program in New Jersey. J Econ Entomol (2002) 0.91

A new biodegradable nanocomposite based on polyhedral oligomeric silsesquioxane nanocages: cytocompatibility and investigation into electrohydrodynamic jet fabrication techniques for tissue-engineered scaffolds. Biotechnol Appl Biochem (2009) 0.91

Interactions between endothelial cells and a poly(carbonate-silsesquioxane-bridge-urea)urethane. Biomaterials (2005) 0.91

Tissue-engineered heart valve: future of cardiac surgery. World J Surg (2012) 0.90

Best evidence for medical therapy for carotid artery stenosis. J Vasc Surg (2013) 0.90

Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver. FASEB J (2005) 0.90

Polyhedral oligomeric silsequioxane-polyurethane nanocomposite microvessels for an artificial capillary bed. Biomaterials (2006) 0.90

Role of prosthetic conduits in coronary artery bypass grafting. Eur J Cardiothorac Surg (2011) 0.90